Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jonathan Wasilko

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Communications|June 17, 2020
Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20David Jonathan Wasilko, Zachary Lee Johnson, Mark Ammirati, et al.
Nature Structural & Molecular Biology|December 15, 2022
Structural basis of the acyl-transfer mechanism of human GPAT1Zachary Lee Johnson, Mark Ammirati, David Jonathan Wasilko, et al.
Nature Communications|August 31, 2024
Structural basis for CCR6 modulation by allosteric antagonistsDavid Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Communications|June 17, 2020
Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20David Jonathan Wasilko, Zachary Lee Johnson, Mark Ammirati, et al.
Nature Structural & Molecular Biology|December 15, 2022
Structural basis of the acyl-transfer mechanism of human GPAT1Zachary Lee Johnson, Mark Ammirati, David Jonathan Wasilko, et al.
Nature Communications|August 31, 2024
Structural basis for CCR6 modulation by allosteric antagonistsDavid Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
Pageof 1